Research Article
Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization
Table 1
Summary of proliferation effects with PEDF and NP-PEG-PEDF-treated HUVECs under high glucose (30 mmol/L).
| Time points | 10%FBS | NP-PEG | PEDF | NP-PEG-PEDF | 1000 ng/mL | 1000 ng/mL | 100 ng/mL | 10 ng/mL | 1000 ng/mL | 100 ng/mL | 10 ng/mL |
| 24 h | Mean | 1 | 94.27 | 80.33 | 77.34 | 69.15 | 54.19 | 45.83 | 40.34 | | SEM | | 5.41 | 5.90 | 2.97 | 7.25 | 4.39 | 4.33 | 8.92 | 48 h | Mean | 1 | 91.49 | 78.26 | 79.23 | 80.22 | 58.13 | 67.12 | 61.29 | | SEM | | 6.87 | 3.69 | 4.89 | 5.32 | 5.02 | 3.71 | 10.23 | 72 h | Mean | 1 | 91.12 | 83.89 | 86.13 | 88.3 | 64.29 | 63.12 | 59.56 | | SEM | | 4.23 | 4.97 | 5.65 | 7.21 | 3.27 | 3.92 | 13.21 |
|
|